Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

KTRA | Kintara Therapeutics Inc

Index	-	P/E	-	EPS (ttm)	-9.41	Insider Own	4.50%	Shs Outstand	1.69M	Perf Week	-6.90%
Market Cap	6.80M	Forward P/E	-	EPS next Y	-0.61	Insider Trans	0.00%	Shs Float	1.66M	Perf Month	-10.93%
Income	-15.02M	PEG	-	EPS next Q	-0.58	Inst Own	2.67%	Short Float / Ratio	0.58% / 0.43	Perf Quarter	-24.95%
Sales	0.00M	P/S	-	EPS this Y	88.78%	Inst Trans	-	Short Interest	0.01M	Perf Half Y	8.31%
Book/sh	-5.86	P/B	-	EPS next Y	40.87%	ROA	-147.03%	Target Price	14.00	Perf Year	-19.30%
Cash/sh	0.88	P/C	4.45	EPS next 5Y	-	ROE	-233.90%	52W Range	2.70 - 15.50	Perf YTD	-43.25%
Dividend	-	P/FCF	-	EPS past 5Y	49.09%	ROI	-2054.58%	52W High	-74.77%	Beta	0.99
Dividend %	-	Quick Ratio	1.06	Sales past 5Y	0.00%	Gross Margin	-	52W Low	44.81%	ATR	0.38
Employees	17	Current Ratio	1.06	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	45.17	Volatility	9.47% 9.74%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	52.55%	Profit Margin	-	Rel Volume	0.60	Prev Close	3.87
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Sep 18 AMC	Payout	-	Avg Volume	22.19K	Price	3.91
Recom	2.00	SMA20	-5.66%	SMA50	-4.31%	SMA200	-13.74%	Volume	13,268	Change	1.03%

Oct-02-23 08:00AM	Kintara Therapeutics to Present at the LD Micro Main Event XVI Conference (PR Newswire)
Sep-25-23 07:30AM	Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting (PR Newswire)
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Sep-18-23 04:25PM	Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update (PR Newswire) -11.54%
Sep-05-23 08:00AM	Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting (PR Newswire)
05:00PM	Loading…
Aug-17-23 05:00PM	Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023 (PR Newswire)
Aug-09-23 08:16AM	Kintara Therapeutics to Present at the Emerging Growth Conference (PR Newswire)
Aug-08-23 07:00AM	Presenting on the Emerging Growth Conference on August 9 & 10 Register Now (GlobeNewswire)
Jul-19-23 08:00AM	Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C. (PR Newswire)
Jun-30-23 11:07AM	Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy (Zacks)
Jun-28-23 04:15PM	Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001 (PR Newswire)
Jun-16-23 08:00AM	Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference (PR Newswire)
May-19-23 08:30AM	Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society (PR Newswire)
May-11-23 08:15AM	Kintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Update (PR Newswire) -6.74%
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
08:30AM	Loading…
May-08-23 08:30AM	Kintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference (PR Newswire) -5.04%
May-01-23 08:30AM	Kintara Therapeutics to Present at the Aegis Capital Virtual Conference (PR Newswire)
Apr-14-23 12:00PM	Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting (PR Newswire)
Mar-15-23 08:00AM	Kintara Therapeutics to Present Two Posters at the 2023 American Association for Cancer Research Annual Meeting (PR Newswire) +17.08%
Mar-10-23 08:30AM	Kintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023 (PR Newswire) -12.61%
Feb-14-23 05:00PM	Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
Jan-30-23 08:00AM	Kintara Therapeutics to Present at the 2023 BIO CEO & Investor Conference (PR Newswire) -8.00%
Jan-09-23 08:30AM	Kintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023 (PR Newswire)
Dec-15-22 08:00AM	Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG) (PR Newswire) +14.98%
Dec-02-22 09:47AM	10 Pump and Dump Stocks Hedge Funds Like (Insider Monkey) -13.09%
Dec-01-22 08:00AM	Kintara Therapeutics to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 (PR Newswire) +32.24%
Nov-30-22 08:00AM	Kintara Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) +12.61%
Nov-28-22 08:00AM	Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer (PR Newswire) +18.24%
Nov-18-22 08:00AM	Kintara Therapeutics Presents Three Posters at the 2022 Society for Neuro-Oncology Annual Meeting (PR Newswire)
Nov-11-22 08:00AM	Kintara Announces One-for-Fifty Reverse Stock Split (PR Newswire) -19.21%
05:20PM	Loading…
Nov-09-22 05:20PM	Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update (PR Newswire) -5.02%
Oct-19-22 08:15AM	Kintara Therapeutics Pauses REM-001 Program to Conserve Funds to Support VAL-083 International Registrational Study (PR Newswire) +20.58%
Sep-27-22 08:15AM	Kintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Update (PR Newswire) -19.50%
Sep-08-22 07:00AM	Kintara Therapeutics Announces Three Abstracts Have Been Accepted for the 2022 Society for Neuro-Oncology Annual Meeting (PR Newswire)
Aug-09-22 09:00AM	Kintara Therapeutics Receives Study May Proceed Letter from the FDA for REM-001 for Cutaneous Metastatic Breast Cancer (PR Newswire) -9.50%
Aug-03-22 08:30AM	Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital (PR Newswire) +38.26%
Jun-21-22 08:00AM	Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference (PR Newswire) +18.75%
Jun-15-22 09:00AM	Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma (PR Newswire) +25.11%
Jun-10-22 09:00AM	Kintara Therapeutics to Present at the JMP Securities Life Sciences Conference (PR Newswire)
Jun-03-22 09:00AM	Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement (PR Newswire)
May-27-22 09:30AM	Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma (PR Newswire)
May-17-22 07:00AM	7 Penny Stocks With 10x Potential This Year (InvestorPlace)
May-13-22 08:00AM	Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update (PR Newswire) +11.37%
Apr-27-22 09:00AM	Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -16.55%
Apr-26-22 07:30AM	Kintara Therapeutics to Present at the Planet MicroCap Showcase 2022 (PR Newswire) +14.69%
Apr-14-22 04:05PM	Kintara Announces Closing of $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (PR Newswire)
Apr-12-22 11:47AM	Here's Why Kintara Therapeutics (NASDAQ:KTRA) Must Use Its Cash Wisely (Simply Wall St.) -30.71%
08:30AM	Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (PR Newswire)
Apr-11-22 02:30PM	Kintara Therapeutics Presents Data at the 2022 American Association for Cancer Research Annual Meeting (PR Newswire) +35.41%
Mar-22-22 08:00AM	Kintara Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference (PR Newswire)
Mar-15-22 07:00AM	Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting (PR Newswire)
Feb-14-22 06:10AM	KTRA: A Farewell to GBM (Zacks Small Cap Research)
Feb-11-22 08:15AM	Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
Feb-04-22 07:00AM	Kintara Therapeutics to Present at BIO CEO & Investor Conference on February 15, 2022 (PR Newswire)
Feb-03-22 07:00AM	Kintara Therapeutics Announces Issuance of New US Patent Related to VAL-083 and MGMT Resistance: Implications for Targeting Brain Tumor Stem Cells (PR Newswire)
Jan-25-22 07:45AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +7.51%
Jan-12-22 08:00AM	Kintara Announces Grant from Luxembourg National Research Fund and Cancer Foundation Luxembourg to Support VAL-083's Mechanism of Action Research in Glioblastoma (PR Newswire)
Jan-05-22 08:00AM	Kintara Therapeutics to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference (PR Newswire) -5.15%
Dec-07-21 08:00AM	Kintara Therapeutics to Present at the MedInvest Oncology Investor Conference on December 9, 2021 (PR Newswire) +8.32%
Nov-30-21 08:00AM	Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma (PR Newswire)
Nov-18-21 08:00AM	Kintara Presents Updates on Two Phase 2 Clinical Studies at the 2021 Society for Neuro-oncology Annual Meeting (PR Newswire)
Nov-17-21 04:42AM	KTRA: More AGILE Sites Greet New CEO (Zacks Small Cap Research)
Nov-15-21 08:15AM	Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update (PR Newswire)
Nov-11-21 08:30AM	Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021 (PR Newswire)
Nov-09-21 08:00AM	Kintara Announces Changes to Executive Leadership Team (PR Newswire)
Nov-03-21 11:13AM	2 Strong Buy Penny Stocks That Are Ready to Boom (TipRanks) +5.87%
Oct-14-21 05:00AM	KTRA: FY21 Financial Results (Zacks Small Cap Research) -9.46%
Oct-11-21 08:00AM	Kintara Therapeutics to Present at the LD Micro Main Event Conference (PR Newswire) +9.04%
Sep-29-21 08:00AM	Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update (PR Newswire) -5.89%
Sep-28-21 01:33PM	Kintara Announces Closing of $15.0 million Offering Priced at a Premium to Market (PR Newswire)
Sep-27-21 05:04AM	KTRA: 2Q:21 Update (Zacks Small Cap Research)
Sep-24-21 08:00AM	Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market (PR Newswire) -21.43%
Sep-22-21 12:30PM	Kintara Posts VAL-083 Data As Adjuvant Therapy In Newly-Diagnosed GBM Patients (Benzinga) -6.06%
08:00AM	Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients (PR Newswire)
Aug-17-21 08:00AM	Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma (PR Newswire)
Aug-12-21 08:00AM	Kintara Therapeutics to Present at the Investor Summit Virtual Conference on August 17, 2021 (PR Newswire)
Aug-06-21 10:20AM	10 Biotech Penny Stocks to Buy According to Reddit (Insider Monkey)
Aug-04-21 08:00AM	Kintara Therapeutics to Present at the BTIG Virtual Biotechnology Conference on August 9, 2021 (PR Newswire)
Jul-09-21 06:29AM	KTRA: Phase II Topline (Zacks Small Cap Research)
Jul-07-21 12:56PM	Biotech Stock Roundup: ALEC Surges on Deal With GSK, CVAC Down on Study Results & More (Zacks)
Jul-01-21 01:36PM	Kintara Therapeutics Shows Encouraging Safety, Efficacy Data From Brain Cancer Study With VAL-083 (Benzinga)
08:00AM	Kintara Reports Topline Results From Phase 2 Clinical Trial of VAL-083 for Recurrent GBM (PR Newswire)
Jun-13-21 10:20PM	Is Kintara Therapeutics (KTRA) A Good Stock To Buy Now? (Insider Monkey)
Jun-07-21 08:00AM	Kintara Therapeutics Set to Join Russell Microcap® Index (PR Newswire)
Jun-03-21 08:00AM	Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors (PR Newswire)
Jun-02-21 08:00AM	Kintara Therapeutics to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 (PR Newswire)
May-26-21 12:25PM	Kintara Stock Soars After Site Activation Update On Glioblastoma Trial (Benzinga) +21.62%
08:00AM	Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma (PR Newswire)
May-14-21 08:00AM	Kintara Therapeutics Announces Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update (PR Newswire)
May-11-21 07:00AM	Kintara Therapeutics, Inc.: Invitation to the Q2 Virtual Investor Summit (Newsfile)
May-05-21 08:00AM	Kintara Therapeutics to Participate at the Benzinga Global Small Cap Conference (PR Newswire)
May-04-21 08:00AM	Kintara Therapeutics Appoints Tamara A. Seymour to Board of Directors (PR Newswire)
Apr-12-21 08:00AM	Kintara Presents Updates on Two Phase 2 Clinical Trials at the 2021 American Association for Cancer Research Annual Meeting (PR Newswire) -7.53%
Apr-05-21 10:51AM	Kintara Taking The Lead In Developing New And Innovative Rare Cancer Therapies (Benzinga)
Mar-17-21 08:00AM	Kintara Therapeutics to Participate in Benzinga Biotech Small Cap Conference (PR Newswire)
Mar-10-21 08:00AM	Kintara Therapeutics to Participate in Maxim Group's 2021 Emerging Growth Virtual Conference (PR Newswire)
Mar-03-21 08:00AM	Kintara Therapeutics Appoints Dr. Mario Lacouture to Scientific Advisory Board for Cutaneous Metastatic Breast Cancer (PR Newswire) -5.37%
Mar-02-21 08:00AM	Kintara Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference (PR Newswire)
Mar-01-21 05:36AM	KTRA: 2Q:21 Update & Target Price Increase (Zacks Small Cap Research)
Feb-17-21 08:00AM	Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Recurrent GBM (PR Newswire) +6.84%

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KTRA | Kintara Therapeutics Inc

Upgrade your FINVIZ experience